Rim Diab: Presenting Protein S Research as a Rebalancing Strategy at ISTH 2026
Rim Diab, Scientist-Postdoc Researcher, Research Assistant, shared a post on LinkedIn:
“Grateful for the opportunity to share our latest research at the International Society on Thrombosis and Haemostasis (ISTH) 2026.
I had the privilege of presenting our work on Protein S as a hemostatic rebalancing strategy in both Factor XI deficiency and von Willebrand disease. It was a valuable experience to discuss these projects with researchers and clinicians from around the world.
A heartfelt thank you to my supervisors, Anne Angelillo-Scherrer and Raja Prince, for their guidance, support, and encouragement throughout these projects. I am also grateful to all my colleagues and collaborators whose contributions made this work possible.
I feel very fortunate to be part of BLEEDnFIRE Therapeutics to contribute to the development of new therapeutic approaches for bleeding disorders.”
Stay updated with Hemostasis Today.
-
Sep 5, 2026, 03:07Luke McLaughlin: The First Community Article of the Haemophilia Rights Project
-
Sep 5, 2026, 03:00Panagiotis Christoforou: Proud to Contribute to Barts Health’s Leading Role in UK Clinical Trials
-
Sep 5, 2026, 02:51Kassiani Maria Nastouli: Honored to Be Cited in the New ESC Guidelines on the Management of CVD and CKD
-
Sep 5, 2026, 02:44Sedat Gül: Is It Time to Reconsider the 24-Hour Antiplatelet Delay After Thrombolysis?
-
Sep 5, 2026, 02:35Balaji Balagani: Exploring Stable vs Unstable vs Complete Coronary Block
-
Sep 5, 2026, 02:28N. Mariana S. Vasquez: Warm vs Cold Autoimmune Hemolytic Anemia for USMLE/NBME Questions
-
Sep 4, 2026, 22:03Maeve Crowley: Haemophilia Treatment Over the Decades and Hope for the Future
-
Sep 4, 2026, 22:01Lama Skieker: Understanding Thrombocytopenia in Malaria
-
Sep 4, 2026, 22:00Hiten Patel: How an IVC Filter Helps Prevent Pulmonary Embolism